Dechema 3D Cell Culture 2021
From bench to applications: Get updated about 3D cell culture as predictive model systems and the translation from models to applications!
Since our first symposium in 2009, the 3D Cell Culture conference series has developed into a ‘place to be’ for experts in this field. 3DCC2021 will highlight newest developments and the translation of models to applications. Success stories and trends like 3D models for personalized medicine will be presented as well as innovative technologies. Relevant disease models, applications of 3D models in clinic and industry, predictive cell models for compound characterization, safety and toxicity testing, and a range of enabling technologies will be covered.In addition to scientific presentations, the exhibition will showcase practical applications, products and solutions and further stimulate discussion between researchers, solution providers and users.
We look forward to meeting you at 3DCC 2021 in Freiburg!
The 3D Cell Culture conference is an initiative of the DECHEMA working groups “Cell Culture Technology” and “Medical Biotechnology”. TEDD is a co-organizer and will feature the exhibition booth.
- Mary K. Estes , USA
- Suzanne C. Fitzpatrick , USA
- Martin Fussenegger, CH
- Jos Kleinjans , NL
- Wolfgang Sommergruber , A
- Advanced cell culture models for understanding of diseases and substance testing
- Complex and multi-cell type models
- Organ-on-a-chip and microphysiological systems
- Models for personalized medicine
- In vitro application of patient-derived tissues
- Translation, clinical and industrial applications: How can models be turned into solutions?
- Success stories and current developments both for clinical and industrial applications
- What regulatory aspects need to be considered, e.g. in the context of preclinical drug evaluation, and where are the current gaps between 3D models and clinic?
- Innovative enabling technologies: The successful development and application of 3D cell culture relies on innovative, advanced analytics and specific assay development as well as on imaging technologies.
- Bioinformatics, systems biology and modelling for the targeted development of 3D cell culture.
- New devices or technologies like 3D printing and bioprinting
- High-throughput and automatization for rapid compound screening.
Start date: 5 May 2021
End date: 7 May 2021
Konzerthaus Freiburg, Germany